This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

How Is Recovery From Social Anxiety Disorder Defined?

Julio Bobes, M.D., Ph.D.

Published: May 21, 1998

Abstract

Recovery in social anxiety disorder (social phobia) is a poorly defined concept. Since the onset of social anxiety disorder typically occurs during adolescence, a time when social skills and academic attainment are of particular importance, recovery is difficult to assess. Assessment of global improvement over 3 domains—symptoms, functionality, and well-being or overall severity of illness—is needed. This article describes currently available rating scales for social anxiety and uses data from clinical studies to assess whether improvement can be defined quantitatively in terms of scores on these rating scales. The main criteria have changed little over the past few years, with most investigators looking for a prespecified response on a single generic or specific rating scale for clinical severity. A better approach may be to employ a multiaxial system that uses a number of rating scales to measure both global and specific symptoms, disability, and quality of life.
(J Clin Psychiatry 1998;59[suppl 17]:12–16)


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 59

Quick Links: Journal

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...